Intravascular contrast agents suitable for magnetic resonance imaging

Area of Science:

• Radiology
• Medical Imaging
• Biomedical Engineering

Background:

• Magnetic Resonance Imaging (MRI) is a powerful diagnostic tool.
• Contrast agents enhance MRI signal detection.
• Paramagnetic chelates are being explored for improved MRI contrast.

Purpose of the Study:

• To evaluate chromium EDTA and gadolinium DTPA as intravenous contrast agents for MRI.
• To assess the agents' efficacy in visualizing renal and splenic tissue.
• To document changes in renal appearance post-contrast injection in vivo.

Main Methods:

• In vitro evaluation of two paramagnetic chelates: chromium EDTA and gadolinium DTPA.
• In vivo studies in dogs using a 0.5-T superconducting MRI scanner.
• Confirmation of diagnoses using gamma camera imaging with Tc-99m-labeled tracers.

Main Results:

• Contrast-enhanced MRI successfully diagnosed acute splenic and renal infarction in dogs.
• Observed changes in renal appearance following contrast agent administration.
• Paramagnetic agents demonstrated potential for functional and perfusion assessment.

Conclusions:

• Intravenous paramagnetic contrast agents are effective for MRI.
• These agents offer a valuable mechanism for assessing tissue function and perfusion.
• Further research into paramagnetic chelates for MRI is warranted.